Targeting the ATR-CHK1 Axis in Cancer Therapy

Targeting the DNA damage response (DDR) is a new therapeutic approach in cancer that shows great promise for tumour selectivity. Key components of the DDR are the ataxia telangiectasia mutated and Rad3 related (ATR) and checkpoint kinase 1 (CHK1) kinases. This review article describes the role of AT...

Descripción completa

Detalles Bibliográficos
Autores principales: Rundle, Stuart, Bradbury, Alice, Drew, Yvette, Curtin, Nicola J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447951/
https://www.ncbi.nlm.nih.gov/pubmed/28448462
http://dx.doi.org/10.3390/cancers9050041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447951/
https://www.ncbi.nlm.nih.gov/pubmed/28448462
http://dx.doi.org/10.3390/cancers9050041

Ejemplares similares